Lyra therapeutics to present at jefferies healthcare conference

Watertown, mass., june 02, 2023 (globe newswire) -- lyra therapeutics, inc. (nasdaq: lyra), a clinical-stage biotechnology company developing innovative therapies for the localized treatment of patients with chronic rhinosinusitis (crs), today announced that maria palasis, ph.d., president and chief executive officer, will present at the jefferies healthcare conference in new york, ny on wednesday, june 7, 2023, at 10:30 a.m. et.
LYRA Ratings Summary
LYRA Quant Ranking